Biosimilars on the rise
05. Oktober 2024
In the Effecten Spiegel financial podcast, Formycon CFO Enno Spillner talks about biosimilars, the market's growth prospects and Formycon's strategy and recent regulatory successes. The podcast is available in German.
You are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information
